[Skip to Content]
[Skip to Content Landing]
Citations 0
August 11, 1999

Infant Growth After In Utero Exposure to Zidovudine

Author Affiliations

Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;282(6):527-529. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-6-jbk0811

To the Editor: While Ms Culname and colleagues1 report that children born to human immunodeficiency virus (HIV)–infected women and exposed to zidovudine in utero have no difference in growth accretion compared with unexposed counterparts, it is not known whether these children grow less than infants born to healthy seronegative mothers.2